Neuroprotective effects of VPA therapeutic metabolites have been reported in a wide range of acute central nervous system injury models, including post-traumatic inflammation caused by spinal cord injury [108]
Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Systemic side effects are rare in available dermatology studies, though long-term safety data remains limited outside specialist settings
Lai H, Lim Y
It Promotes a Healthy Lip Barrier Just as you emphasize strengthening your skin barrier, you should do the same for your lip barrier